Genitourin Med. 1997 Oct;73(5):355-61. doi: 10.1136/sti.73.5.355.
To describe the establishment and outcomes of a regional programme of continuing long term surveillance of antibiotic susceptibility of Neisseria gonorrhoeae over the period 1992-4.
Laboratories in 17 countries in the WHO Western Pacific Region participated in a continuing programme of surveillance of the susceptibility of gonococci to an agreed group of antibiotics over 3 years. Established techniques were used and these included quality control and proficiency testing systems.
About 20,000 gonococci were examined over a 3 year period. Resistance to the penicillins through beta lactamase production or chromosomal mechanisms was widespread, with further changes evident over the 3 years. Spectinomycin resistance was infrequently encountered but high level tetracycline resistance was present in most participating centres, with some having high proportions of tetracycline resistant organisms. Quinolone resistance increased and became widespread throughout the region in the 3 years, ultimately involving all but one centre. Both the number and minimum inhibitory concentrations of quinolone resistant isolates increased markedly.
Patterns of gonococcal resistance to antibiotics continue to evolve, at times rapidly, and have the potential for wide and rapid dissemination. Regional surveillance programmes can be developed by using and expanding existing resources. Data thus derived were applied to the development of appropriate treatment regimens in the region, and emphasised further the need for a global expansion of the programme of integrated surveillance of gonococcal resistance.
描述1992 - 1994年期间淋病奈瑟菌抗生素敏感性区域长期持续监测项目的建立及结果。
世界卫生组织西太平洋区域17个国家的实验室参与了一项为期3年的持续项目,该项目监测淋球菌对一组商定抗生素的敏感性。采用既定技术,包括质量控制和能力验证系统。
在3年期间共检测了约20000株淋球菌。通过产生β-内酰胺酶或染色体机制对青霉素产生耐药性的情况很普遍,且在这3年中出现了进一步变化。壮观霉素耐药情况很少见,但大多数参与中心存在高水平四环素耐药,一些中心四环素耐药菌株比例很高。喹诺酮耐药性在3年中增加并在整个区域广泛传播,最终除一个中心外所有中心都受到影响。喹诺酮耐药菌株的数量和最低抑菌浓度均显著增加。
淋球菌对抗生素的耐药模式持续演变,有时变化迅速,且有广泛快速传播的可能性。可利用并扩展现有资源开展区域监测项目。由此获得的数据被应用于该区域适当治疗方案的制定,并进一步强调了全球扩大淋球菌耐药性综合监测项目的必要性。